scholarly journals Clinical, metabolic and neurological disorders in full-term newborns from mothers with gestational diabetes mellitus

Author(s):  
O. V. Remneva ◽  
O. V. Rozhkova ◽  
T. M. Cherkasova ◽  
Yu. V. Korenovskiy ◽  
N. V. Trukhacheva ◽  
...  

Objective. To determine the clinical and metabolic changes in children born from mothers with gestational diabetes mellitus and to predict perinatal injury of the central nervous system (CNS), taking into account the level of maternal hyperglycemia.Material and methods. The period of early postnatal adaptation was analyzed in 258 full-term infants, who were divided into two groups, depending on the glucose level in the mother’s venous blood during pregnancy: Group 1: 5,1–5,6 mmol/L, Group 2: 5,7–7,0 mmol/L.Results. Based on clinical, functional and laboratory markers (electrolyte balance and carbohydrate metabolism in the blood of a newborn) there was established a correlation between the severity of maternal hyperglycemia and the severity of neonatal disorders. In Group II infants born from mothers with more severe hyperglycemia are more likely to have a respiratory distress syndrome and ischemic-hypoxic injury of the central nervous system in combination with excess birth weight which significantly complicates postnatal adaptation.Conclusion. The concentration of neuron-specific enolase of 4,9 ng/ml in the fetal amniotic fluid is an antenatal marker of perinatal damage to the central nervous system in a newborn.

2016 ◽  
Vol 88 (10) ◽  
pp. 82-86 ◽  
Author(s):  
E V Surkova

The review considers the current views on the central nervous system (CNS) in diabetes mellitus (DM). It discusses an attitude towards the term «diabetic encephalopathy». The data of investigations of cognitive functions in types 1 and 2 DM and the brain structural imaging results obtained using up-to-date technologies are considered. The results of studies of the factors that induce cerebral changes in DM and their associated cognitive impairments are given. There is evidence that hyperglycemia has a more considerable impact on the above processes than hypoglycemia; other possible factors, apart from blood glucose control, are set out. The current views on the function of insulin in the CNS and the relationship of central insulin resistance to Alzheimer’s disease are outlined. There are current data on intranasal insulin application that is still exploratory, but, as might be judged from the findings, may by a promising method for the treatment and prevention of cognitive decline in both patients with DM and those without this condition.


Author(s):  
Joel Ramírez-Emiliano ◽  
Martha E. Fajardo-Araujo ◽  
Ismael Zúñiga-Trujillo ◽  
Victoriano Pérez-Vázquez ◽  
Cuauhtémoc Sandoval-Salazar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document